Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337467
Status:
COMPLETED
Last Update Posted:
2010-07-19
First Post:
2006-06-14
Brief Title:
Phase IIIb Study to Evaluate the Effectiveness and Safety of AtazanavirRitonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus HIV-Infected Subjects Evidencing Virologic Suppression
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Human Immunodeficiency Virus HIV Infections |
Keywords:
| Name | View |
|---|---|
| HIV-Infected Patients Evidencing Virologic Suppression | View |